ENDRA Life Sciences (NDRA) Treasury Shares (2016 - 2022)

ENDRA Life Sciences (NDRA) has reported Treasury Shares for 7 consecutive years, with $2.4 million the latest figure, recorded in Q1 2022.

• In Q1 2022, Treasury Shares fell 8.45% year-over-year to $2.4 million; the TTM figure through Mar 2022 stood at $2.4 million (down 8.45% YoY), while the FY2021 annual figure was $121818.0, down 98.05% from the prior year.
• Treasury Shares advanced to $2.4 million in Q1 2022 per NDRA's latest filing, from $121818.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $13.5 million in Q4 2019 and bottomed at $121818.0 in Q4 2021.
• Historically, Treasury Shares has averaged $4.9 million across 5 years, with a median of $2.6 million in 2018.
• Annual changes were most pronounced in 2019 — Treasury Shares surged 413.58% — and 2021, when it sank 98.05%.
• ENDRA Life Sciences' Treasury Shares stood at $2.6 million in 2018, then soared by 413.58% to $13.5 million in 2019, then sank by 53.68% to $6.3 million in 2020, then tumbled by 98.05% to $121818.0 in 2021, then soared by 1900.66% to $2.4 million in 2022.
• Business Quant data shows NDRA's Treasury Shares at $2.4 million in Q1 2022, $121818.0 in Q4 2021, and $2.4 million in Q3 2021.